Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Wuxi Apptec 2359.HK | Pharmaceuticals: Major | $64.1B | -3% | +51% | +38% | 44% | 19.5× |
| Jiangsu Hengrui Pharmaceuticals 1276.HK | Pharmaceuticals: Major | $44.9B | -6% | -24% | +11% | 27% | 28.1× |
| Hansoh Pharma 3692.HK | Pharmaceuticals: Major | $25.3B | -5% | -3% | +25% | 38% | 25.8× |
| Wuxi Bio 2269.HK | Biotechnology | $23.1B | -11% | +35% | +22% | 32% | 26.5× |
| Innovent Biologics 1801.HK | Pharmaceuticals: Major | $18.9B | -4% | +4% | +43% | 17% | 52.3× |
| Jd Health 6618.HK | Drugstore Chains | $13.3B | -12% | -15% | +26% | 6% | 14.7× |
| Sichuan Kelun-Biotech Biopharmaceutical 6990.HK | Pharmaceuticals: Major | $13.0B | -9% | -1% | +44% | -38% | 1,176.1× |
| Sbp 1177.HK | Pharmaceuticals: Major | $12.2B | 0% | +5% | +15% | 30% | 17.5× |
| Cspc Pharma 1093.HK | Biotechnology | $12.0B | -10% | +10% | +25% | 28% | 9.1× |
| WuXi XDC Cayman 2268.HK | Miscellaneous Commercial Services | $10.4B | -13% | +20% | +42% | 28% | 35.8× |
| Pharmaron Beijing 3759.HK | Pharmaceuticals: Major | $9.65B | -1% | +48% | +24% | 14% | 20.8× |
| Genscript Biotech 1548.HK | Biotechnology | $8.69B | -8% | +133% | +53% | 12% | 294.1× |
| Shanghai Pharmaceuticals 2607.HK | Pharmaceuticals: Major | $8.25B | -1% | -7% | +9% | 3% | 6.3× |
| Shanghai Fosun Pharmaceutical (Group) 2196.HK | Pharmaceuticals: Major | $7.74B | -12% | -15% | +10% | 6% | 9.0× |
| Asymchem Laboratories (Tianjin) 6821.HK | Pharmaceuticals: Major | $7.10B | -22% | +17% | +24% | 17% | 24.4× |
| Akeso 9926.HK | Pharmaceuticals: Major | $7.01B | -35% | -48% | +42% | -25% | n/a |
| Sinopharm 1099.HK | Medical Distributors | $6.74B | +10% | 0% | +3% | 3% | 6.2× |
| RemeGen 9995.HK | Pharmaceuticals: Major | $6.07B | -6% | -28% | +293% | 61% | 6.3× |
| Ali Health 0241.HK | Information Technology Services | $5.51B | -10% | -31% | +14% | 5% | 18.1× |
| Hangzhou Tigermed Consulting 3347.HK | Biotechnology | $4.75B | -17% | 0% | +22% | 10% | 59.8× |
| Fameglow 3774.HK | Medical/Nursing Services | $4.54B | +46% | n/a | +36% | 11% | n/a |
| Guangzhou Baiyunshan Pharmaceutical 0874.HK | Pharmaceuticals: Major | $4.48B | -4% | -23% | +6% | 3% | 7.0× |
| 3SBio 1530.HK | Biotechnology | $4.28B | -10% | -31% | +102% | 61% | 12.0× |
| Livzon Pharmaceutical 1513.HK | Pharmaceuticals: Major | $3.73B | +18% | -9% | -10% | 19% | 11.3× |
| JOINN Laboratories (China) 6127.HK | Biotechnology | $3.70B | -24% | +6% | +17% | -4% | 14.4× |
| China Resources Pharmaceutical 3320.HK | Pharmaceuticals: Major | $3.60B | -3% | -7% | +8% | 4% | 5.8× |
| Shanghai Junshi Biosciences 1877.HK | Pharmaceuticals: Major | $3.49B | -16% | -38% | +36% | -14% | n/a |
| Simcere Pharmaceutical 2096.HK | Pharmaceuticals: Major | $3.42B | -5% | -5% | +27% | 18% | 13.5× |
| Shanghai Henlius Biotech 2696.HK | Pharmaceuticals: Major | $3.05B | -17% | -39% | +33% | 12% | 21.3× |
| China Medical System 0867.HK | Pharmaceuticals: Major | $2.95B | -8% | -15% | +15% | 20% | 9.8× |
| XtalPi 2228.HK | Biotechnology | $2.87B | -11% | -34% | +4% | -127% | n/a |
| Zai Lab 9688.HK | Biotechnology | $2.79B | -5% | +23% | 0% | -63% | n/a |
| Sunshine Lake Pharma 6887.HK | Biotechnology | $2.72B | -8% | -7% | +20% | -3% | n/a |
| InSilico Medicine Cayman TopCo 3696.HK | Pharmaceuticals: Major | $2.40B | -12% | -33% | +153% | -7% | 85.2× |
| Keymed Biosciences 2162.HK | Pharmaceuticals: Major | $2.39B | -22% | +7% | 0% | -73% | 18.2× |
| HUTCHMED (China) 0013.HK | Pharmaceuticals: Major | $2.38B | -6% | +14% | -9% | -6% | 35.9× |
| Shanghai Conant Optical 2276.HK | Medical Specialties | $2.25B | -2% | -17% | +8% | 29% | 22.1× |
| Health and Happiness (H&H) International 1112.HK | Pharmaceuticals: Other | $2.15B | +25% | +108% | +24% | 16% | 13.2× |
| InnoCare Pharma 9969.HK | Pharmaceuticals: Major | $2.01B | -13% | -10% | +146% | 35% | 32.2× |
| Grand Pharmaceutical 0512.HK | Pharmaceuticals: Major | $1.93B | -8% | -25% | +7% | 13% | 9.4× |
| Shandong Weigao Group Medical Polymer 1066.HK | Medical Specialties | $1.82B | -5% | -8% | +7% | 14% | 8.2× |
| United Laboratories International 3933.HK | Pharmaceuticals: Major | $1.80B | -2% | -20% | -13% | 5% | 13.0× |
| Shenzhen Hepalink Pharmaceutical 9989.HK | Pharmaceuticals: Major | $1.78B | +1% | -13% | -1% | 8% | 8.7× |
| Consun Pharmaceutical 1681.HK | Pharmaceuticals: Major | $1.65B | -1% | +8% | +15% | 35% | 9.2× |
| Angelalign Technology 6699.HK | Medical Specialties | $1.62B | -6% | -8% | +84% | 9% | 52.5× |
| Vigonvita Life Sciences 2630.HK | Pharmaceuticals: Generic | $1.59B | -5% | -5% | +763% | -327% | n/a |
| Fujian Haixi Pharmaceuticals 2637.HK | Biotechnology | $1.47B | -1% | -32% | +25% | 33% | 46.4× |
| CanSino Biologics 6185.HK | Biotechnology | $1.36B | -23% | -23% | +36% | -4% | 60.5× |
| Ping An Healthcare and Technology 1833.HK | Medical/Nursing Services | $1.36B | -13% | -47% | +8% | 3% | 33.5× |
| Shenzhen Edge Medical 2675.HK | Medical Specialties | $1.21B | -23% | -51% | +132% | 2% | 120.2× |
| CStone Pharmaceuticals 2616.HK | Pharmaceuticals: Major | $1.21B | +16% | -22% | +117% | -89% | n/a |
| Mabwell (Shanghai) Bioscience 2493.HK | Pharmaceuticals: Major | $1.20B | -8% | -29% | +21% | -127% | n/a |
| Ascentage Pharma Group International 6855.HK | Pharmaceuticals: Major | $1.18B | -19% | -34% | +70% | -220% | n/a |
| HBM 2142.HK | Pharmaceuticals: Other | $1.12B | -4% | -18% | +55% | 44% | 11.7× |
| Duality Biotherapeutics 9606.HK | Biotechnology | $1.06B | -46% | -58% | -5% | -181% | n/a |
| Everest Medicines 1952.HK | Pharmaceuticals: Major | $1.05B | -28% | -20% | +193% | -5% | 23.2× |
| Shandong Xinhua Pharmaceutical 0719.HK | Pharmaceuticals: Other | $1.03B | -8% | -19% | -1% | 4% | 6.2× |
| SSY 2005.HK | Pharmaceuticals: Major | $948M | -6% | +8% | -4% | 12% | 12.5× |
| Genfleet Therapeutics (Shanghai) 2595.HK | Pharmaceuticals: Major | $912M | -34% | -42% | -55% | -457% | n/a |
| Shanghai Haohai Biological Technology 6826.HK | Medical Distributors | $897M | +2% | -24% | -5% | -2% | 7.7× |
| Suzhou Ribo Life Science 6938.HK | Pharmaceuticals: Generic | $860M | -25% | -32% | +4% | -187% | n/a |
| Sihuan Pharmaceutical 0460.HK | Pharmaceuticals: Other | $856M | +3% | -34% | +30% | 15% | 8.7× |
| Modern Dental 3600.HK | Medical Specialties | $844M | -5% | +24% | +12% | 22% | 8.5× |
| Cofoe Medical Technology 1187.HK | Medical Specialties | $836M | +3% | -11% | +40% | 10% | 13.1× |
| Hygeia Healthcare 6078.HK | Pharmaceuticals: Major | $811M | +11% | -3% | +2% | 14% | 10.4× |
| Sichuan Neautus Traditional Chinese 2206.HK | Pharmaceuticals: Major | $779M | n/a | n/a | +7% | 8% | n/a |
| LifeTech Scientific 1302.HK | Medical Specialties | $771M | -1% | -30% | +1% | 12% | 19.8× |
| Zylox-Tonbridge Medical Technology 2190.HK | Medical Specialties | $768M | -13% | -16% | +39% | 25% | 14.4× |
| Nanjing Leads Biolabs 9887.HK | Biotechnology | $764M | -29% | -50% | n/a | -108% | n/a |
| China Shineway Pharmaceutical 2877.HK | Pharmaceuticals: Other | $760M | +6% | -8% | -18% | 25% | 7.6× |
| Jinxin Fertility 1951.HK | Medical/Nursing Services | $758M | +1% | -4% | +7% | 11% | 23.1× |
| CARsgen Therapeutics 2171.HK | Pharmaceuticals: Major | $751M | -16% | -45% | +68% | -170% | n/a |
| Luye Pharma 2186.HK | Pharmaceuticals: Major | $736M | -9% | -32% | +3% | 18% | 7.1× |
| China Traditional Chinese Medicine 0570.HK | Pharmaceuticals: Major | $716M | -6% | -31% | -16% | 0% | n/a |
| Shaanxi Micot Pharmaceutical Technology 2335.HK | Biotechnology | $715M | +8% | n/a | n/a | n/a | n/a |
| Shanghai INT Medical Instruments 1501.HK | Medical Specialties | $700M | -11% | -25% | +35% | 21% | 15.9× |
| Alphamab Oncology 9966.HK | Biotechnology | $666M | -25% | -38% | -32% | -38% | 24.0× |
| AK Medical 1789.HK | Medical Specialties | $642M | +4% | -23% | +16% | 26% | 10.5× |
| Beijing Chunlizhengda Medical Instruments 1858.HK | Medical Specialties | $631M | +1% | -28% | -9% | 31% | 8.5× |
| CK Life Sciences International (Holdings) 0775.HK | Pharmaceuticals: Other | $613M | -1% | -30% | 0% | 0% | n/a |
| Alebund Pharmaceuticals (Jiangsu) 9637.HK | Biotechnology | $595M | +18% | n/a | +674% | -495% | n/a |
| Lepu Biopharma 2157.HK | Pharmaceuticals: Major | $580M | -34% | -43% | +47% | 7% | 53.6× |
| Abbisko Cayman 2256.HK | Pharmaceuticals: Major | $578M | -17% | -39% | -83% | -520% | n/a |
| Beijing Tong Ren Tang Chinese Medicine 3613.HK | Pharmaceuticals: Major | $577M | -6% | -26% | -21% | 32% | 10.2× |
| Ascletis Pharma 1672.HK | Biotechnology | $571M | -24% | -72% | -59% | -71,976% | n/a |
| Frontage 1521.HK | Biotechnology | $542M | +93% | +113% | +10% | 8% | 24.6× |
| LongBio Pharma (Suzhou) 1779.HK | Biotechnology | $510M | -30% | n/a | n/a | n/a | n/a |
| Tong Ren Tang Technologies 1666.HK | Pharmaceuticals: Major | $491M | -3% | -19% | -14% | 12% | 7.3× |
| TenNor Therapeutics Suzhou 6872.HK | Biotechnology | $470M | -33% | n/a | n/a | n/a | n/a |
| Qyuns Therapeutics 2509.HK | Biotechnology | $428M | -9% | -11% | +230% | 56% | 10.2× |
| China Isotope & Radiation 1763.HK | Medical Specialties | $428M | -10% | -41% | -5% | 13% | 6.0× |
| Jenscare Scientific 9877.HK | Medical Specialties | $415M | -17% | -32% | +993% | -106% | n/a |
| Edding Genor 6998.HK | Biotechnology | $410M | -5% | -35% | +1,418% | 26% | n/a |
| Hanx Biopharmaceuticals (Wuhan) 3378.HK | Biotechnology | $409M | -19% | -24% | n/a | n/a | n/a |
| Jacobio Pharmaceuticals 1167.HK | Biotechnology | $404M | -22% | -24% | +286% | 68% | 5.7× |
| Beijing Luzhu Biotechnology 2480.HK | Biotechnology | $396M | 0% | -33% | n/a | n/a | 26.2× |
| OrbusNeich Medical 6929.HK | Medical Specialties | $394M | +1% | -15% | +16% | 23% | 8.4× |
| ADICON 9860.HK | Medical/Nursing Services | $393M | -6% | +5% | +1% | 4% | 24.6× |
| China Resources Medical 1515.HK | Hospital/Nursing Management | $393M | +2% | -10% | 0% | 6% | 5.4× |
| Medcaptain Medical Technology 2041.HK | Medical Specialties | $378M | -9% | n/a | +19% | 2% | n/a |
| Bayzed Health 2609.HK | Hospital/Nursing Management | $375M | -16% | -58% | -2% | 5% | n/a |
| Star Sports Medicine 1609.HK | Medical Specialties | $364M | -10% | -73% | +23% | 37% | n/a |
| BioDlink International 1875.HK | Pharmaceuticals: Major | $334M | -2% | -24% | -51% | -31% | 288.2× |
| Medtide 3880.HK | Biotechnology | $331M | -6% | -17% | +14% | 36% | 10.5× |
| Laekna 2105.HK | Biotechnology | $326M | -1% | -53% | n/a | -57% | n/a |
| IMPACT Therapeutics 7630.HK | Biotechnology | $319M | -32% | -79% | +395% | -173% | n/a |
| Viva Biotech 1873.HK | Biotechnology | $303M | -15% | -18% | +7% | 10% | 8.1× |
| Peijia Medical 9996.HK | Medical Specialties | $296M | -17% | -34% | +21% | -13% | 292.4× |